Thalix 50 mg Capsule

Thalix 50 mg Capsule (Thalidomide)

Thalix 50 mg Capsule contains thalidomide, a medication used primarily in the treatment of multiple myeloma and certain skin conditions related to leprosy. It works by modulating the immune system and inhibiting angiogenesis (the formation of new blood vessels that tumors need to grow).

Key Features

• Contains thalidomide, an immunomodulatory drug.
• Effective in treating multiple myeloma and managing leprosy-related inflammation.
• Modulates immune response and prevents angiogenesis, limiting disease progression.

References

1. Thalidomide Information - Mayo Clinic
   Available from: https://go.drugbank.com/drugs/DB01041
2. Multiple Myeloma Treatment Guidelines - ASCO
   Available from: https://pubmed.ncbi.nlm.nih.gov/21507989/

How it works

Thalidomide modulates the immune response by inhibiting tumor necrosis factor-alpha (TNF-α), suppressing inflammation, and preventing the formation of new blood vessels (anti-angiogenesis), which helps to slow or stop the growth of cancer cells and reduce inflammation in leprosy-related skin conditions.

• Multiple Myeloma: Often used in combination with other treatments for patients with newly diagnosed multiple myeloma.
• Erythema Nodosum Leprosum (ENL): Effective in managing the inflammatory complications of leprosy.

• Drowsiness and dizziness
• Constipation
• Peripheral neuropathy (tingling, numbness, or pain in the hands and feet)
• Swelling of the legs or arms (edema)
• Fatigue

Serious Side Effects (Seek Medical Attention)

• Severe peripheral neuropathy (nerve damage)
• Blood clots (deep vein thrombosis or pulmonary embolism)
• Birth defects (teratogenic effects; contraindicated in pregnancy)
• Severe allergic reactions